Rethinking Quality of Life: Multi-Stakeholder Consensus Calls for Overhaul of Patient-Reported Outcomes in Advanced Blood Cancer Immunotherapies
Executive Overview The landscape of haematological oncology has been fundamentally reshaped by groundbreaking immunotherapies, specifically chimeric antigen receptor (CAR) T-cell therapies and T-cell engaging bispecific antibodies...










































